drugset / Trial / NCT01233739

Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.

NCT01233739

Phase 4 Unknown 108 enrolled Juan A. Arnaiz
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients who present rhizarthrosis diagnostic will be randomized to be treated with chondroitin sulfate or placebo during 24 weeks to study the effect of the treatment with objective and subjective indicators of pain and sensibility.

Timeline

Start
2011-03
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin sulfate Unknown 800 mg Oral

Indications